CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han
Cancer Research and Treatment. 2017;49(4):1001-1011.   Published online 2017 January 13    DOI: https://doi.org/10.4143/crt.2016.546

Excel Download

Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Cancer Research and Treatment. 2017;49(4):1001-1011   Crossref logo
Link1 Link2 Link3

Results of a clinical multicentric randomized phase II study of non-small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone
Lung Cancer. 1995;12(3):307   Crossref logo
Link1 Link2

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Yearbook of Oncology. 2012;2012:187-188   Crossref logo
Link1 Link2

Randomized study of NavelbineR and cisplatin versus vindesine and cisplatin versus NavelbineR alone in 612 patients with advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 1996;16(1):120   Crossref logo
Link1 Link2

Afatinib
Reactions Weekly. 2017;1675(1):19-19   Crossref logo
Link1 Link2 Link3

Afatinib treatment in advanced non-small cell lung cancer
Lung Cancer: Targets and Therapy. 2011;47   Crossref logo
Link1

Afatinib
Reactions Weekly. 2017;1656(1):21-21   Crossref logo
Link1 Link2 Link3

Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer
Lung Cancer. 1993;8(5-6):348   Crossref logo
Link1 Link2

Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: A hoosier oncology group trial
Lung Cancer. 1995;13(2):221-222   Crossref logo
Link1 Link2

Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 2000;29(1):57   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.